Stem Cell Treatment Benefits Three-fourths of MS Patients in Phase 1 Trial – Multiple Sclerosis News Today
Multiple Sclerosis News Today |
Stem Cell Treatment Benefits Three-fourths of MS Patients in Phase 1 Trial
Multiple Sclerosis News Today A stem cell treatment improved the neurological symptoms of three-fourths of the multiple sclerosis patients in a Phase 1 clinical trial, New York researchers reported. The results prompted the team at the Tisch MS Research Center of New York to start … |
